ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

USNA vs TLRY // RSI-14 & 200D SMA MOMENTUM

USANA Health Sciences Inc. (NYSE) VS. Tilray Brands Inc. (NASDAQ) • 15-METRIC TALLY: USNA 8 — TLRY 2
▲ RSI-14 & 200D SMA MOMENTUM LEADER: USNA
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (USNA VS. TLRY) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC USNA TLRY SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 78.30% 28.40% +49.90 USNA /gross-margins <GO>
Return on Invested Capital (ROIC) 7.90% -3.90% +11.80 USNA /roic <GO>
EV/EBITDA & P/E Valuation 2.7x — — TIE /valuation <GO>
Free Cash Flow Yield 3.22% -17.72% +20.94 USNA /fcf-yield <GO>
Operating Margin 4.00% -6.90% +10.90 USNA /operating-margins <GO>
Net Profit Margin 1.20% -13.30% +14.50 USNA /net-margins <GO>
Revenue Growth (YoY) 8.30% 11.50% -3.20 TLRY /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.56 0.20 +3.36 USNA /balance-sheet <GO>
Piotroski F-Score Quality 7/9 5/9 +2.00 USNA /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum ACTIVE 45.3 18.4 +26.86 USNA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 22.9x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $265.0M $390.2M -$125.2M TLRY /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR USNA REV TLRY REV USNA GROSS % TLRY GROSS % USNA FCF TLRY FCF
FY 2025 $925.3M $915.5M 78.3% 28.4% $8.5M -$69.1M
FY 2024 $854.5M $821.3M 81.1% 29.3% $50.9M -$94.6M
FY 2023 $921.0M $788.9M — — $70.6M -$30.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
USNA // BETA —
TLRY // BETA —